BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25924874)

  • 21. Genotype-specific cortisol production associated with Cushing's syndrome adenoma with PRKACA mutations.
    Baba R; Oki K; Gomez-Sanchez CE; Otagaki Y; Itcho K; Kobuke K; Kodama T; Nagano G; Ohno H; Yoneda M; Hattori N
    Mol Cell Endocrinol; 2021 Dec; 538():111456. PubMed ID: 34520814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary bilateral adrenal nodular disease with Cushing's syndrome: varying aetiology.
    Jarial KDS; Walia R; Nahar U; Bhansali A
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28739615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of new potentially pathogenic mutations in two patients with primary pigmented nodular adrenocortical disease (PPNAD) - case reports with literature review.
    Pasternak-Pietrzak K; Stratakis CA; Moszczyńska E; Lecka-Ambroziak A; Staniszewski M; Wątrobińska U; Lyssikatos C; Prokop-Piotrkowska M; Grajkowska W; Pronicki M; Szalecki M
    Endokrynol Pol; 2018; 69(6):675-681. PubMed ID: 30259502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. cAMP signaling in cortisol-producing adrenal adenoma.
    Calebiro D; Di Dalmazi G; Bathon K; Ronchi CL; Beuschlein F
    Eur J Endocrinol; 2015 Oct; 173(4):M99-106. PubMed ID: 26139209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia.
    Storr HL; Mitchell H; Swords FM; Main KM; Hindmarsh PC; Betts PR; Shaw NJ; Johnston DI; Clark AJ; Reznek RH; Grossman AB; Savage MO
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):553-9. PubMed ID: 15521956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "GIANT" macronodular adrenal hyperplasia causing Cushing's syndrome: case report and review of the literature on a clinical distinction of adrenocortical nodular pathology associated with hypercortisolism.
    Cugini P; Battisti P; Di Palma L; Sepe M; Kawasaki T; Uezono K; Sasaki H
    Endocrinol Jpn; 1989 Feb; 36(1):101-16. PubMed ID: 2543545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of Aberrant PKA Activation by Cα Subunit Mutations.
    Calebiro D; Bathon K; Weigand I
    Horm Metab Res; 2017 Apr; 49(4):307-314. PubMed ID: 27813054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: a clinical and molecular genetic investigation.
    Matyakhina L; Freedman RJ; Bourdeau I; Wei MH; Stergiopoulos SG; Chidakel A; Walther M; Abu-Asab M; Tsokos M; Keil M; Toro J; Linehan WM; Stratakis CA
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3773-9. PubMed ID: 15741255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations.
    Nanba K; Omata K; Tomlins SA; Giordano TJ; Hammer GD; Rainey WE; Else T
    Eur J Endocrinol; 2016 Aug; 175(2):K1-6. PubMed ID: 27165862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness and limitations of unilateral adrenalectomy for ACTH-independent macronodular adrenal hyperplasia in a patient with poor glycemic control.
    Kobayashi T; Miwa T; Kan K; Takeda M; Sakai H; Kanazawa A; Tanaka A; Namiki K; Nagao T; Odawara M
    Intern Med; 2012; 51(13):1709-13. PubMed ID: 22790131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [ACTH secretion and adrenocortical responsiveness in Cushing's syndrome due to adrenocortical hyperplasia (author's transl)].
    Suzuki S
    Nihon Naibunpi Gakkai Zasshi; 1976 Aug; 52(8):828-44. PubMed ID: 190054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.
    Groussin L; Jullian E; Perlemoine K; Louvel A; Leheup B; Luton JP; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4324-9. PubMed ID: 12213893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is Disrupted Nucleotide-Substrate Cooperativity a Common Trait for Cushing's Syndrome Driving Mutations of Protein Kinase A?
    Walker C; Wang Y; Olivieri C; V S M; Gao J; Bernlohr DA; Calebiro D; Taylor SS; Veglia G
    J Mol Biol; 2021 Sep; 433(18):167123. PubMed ID: 34224748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenal tuberculosis in Cushing's disease with bilateral macronodular adrenocortical hyperplasia.
    Kwon HS; Kim SI; Yoo SJ; Yoon KH; Lee KW; Kang MW; Son HY; Kang SK; Cha BY
    Endocr J; 2006 Apr; 53(2):219-23. PubMed ID: 16618981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences.
    Espiard S; Drougat L; Libé R; Assié G; Perlemoine K; Guignat L; Barrande G; Brucker-Davis F; Doullay F; Lopez S; Sonnet E; Torremocha F; Pinsard D; Chabbert-Buffet N; Raffin-Sanson ML; Groussin L; Borson-Chazot F; Coste J; Bertagna X; Stratakis CA; Beuschlein F; Ragazzon B; Bertherat J
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E926-35. PubMed ID: 25853793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism?
    Guerin C; Taieb D; Treglia G; Brue T; Lacroix A; Sebag F; Castinetti F
    Endocr Relat Cancer; 2016 Feb; 23(2):R131-42. PubMed ID: 26739832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome.
    Lampron A; Bourdeau I; Hamet P; Tremblay J; Lacroix A
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3611-8. PubMed ID: 16772347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial ACTH-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia clinically affecting only female family members.
    Nies C; Bartsch DK; Ehlenz K; Wild A; Langer P; Fleischhacker S; Rothmund M
    Exp Clin Endocrinol Diabetes; 2002 Sep; 110(6):277-83. PubMed ID: 12373631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microinsertions in PRKACA cause activation of the protein kinase A pathway in cardiac myxoma.
    Tseng IC; Huang WJ; Jhuang YL; Chang YY; Hsu HP; Jeng YM
    J Pathol; 2017 Jun; 242(2):134-139. PubMed ID: 28369983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and endocrinological features of adrenocorticotropic hormone- independent bilateral macronodular adrenocortical hyperplasia.
    Shinojima H; Kakizaki H; Usuki T; Harabayashi T; Ameda K; Koyanagi T
    J Urol; 2001 Nov; 166(5):1639-42. PubMed ID: 11586192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.